Volume 70, Issue 6, Pages (June 2019)

Slides:



Advertisements
Similar presentations
2015 Alzheimer's disease facts and figures Alzheimer's & Dementia: The Journal of the Alzheimer's Association Volume 11, Issue 3, Pages (March.
Advertisements

EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Volume 60, Issue 2, Pages (February 2014)
Volume 62, Issue 6, Pages (June 2015)
Volume 63, Issue 1, Pages (July 2015)
Volume 46, Issue 3, Pages (March 2007)
The impact of hepatitis E in the liver transplant setting
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies  The Emerging.
Adding rosiglitazone to metformin in patients with type 2 diabetes: Effect on diabetes control and metabolic parameters  Hussein Raef, Abdulraof Al-Mahfouz,
Inflammasomes in liver diseases
Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review  Christian Thoma, Christopher P. Day, Michael.
Tiny RNA with great effects: miR-155 in alcoholic liver disease
Comparison of baseline characteristics in participants who subsequently had an incident cardiovascular event or new-onset diabetes in the Prospective.
Personalized Activity Intelligence (PAI) for Prevention of Cardiovascular Disease and Promotion of Physical Activity  Bjarne M. Nes, PhD, Christian R.
MRI and MRE for non-invasive quantitative assessment of hepatic steatosis and fibrosis in NAFLD and NASH: Clinical trials to clinical practice  Parambir.
The impact of hepatitis E in the liver transplant setting
Matthew T. Kitson, Stuart K. Roberts  Journal of Hepatology 
Non-invasive diagnosis of non-alcoholic fatty liver disease
Change in end-tidal carbon dioxide outperforms other surrogates for change in cardiac output during fluid challenge  K Lakhal, M.A. Nay, T Kamel, B Lortat-Jacob,
Individualized prediction of hepatocellular carcinoma occurrence in a large cohort of patients with cirrhosis  Astrid Marot, Jean Henrion, Jean-François.
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies  The Emerging.
M. Sriharibabu, K. Komali, T. Sivakumar, Bhimasen Soren 
Living donor liver transplantation: is the hype over?
Pilot Study of Peripheral Muscle Function in Primary Biliary Cirrhosis: Potential Implications for Fatigue Pathogenesis  Kieren G. Hollingsworth, Julia.
Effect of pioglitazone on biochemical indices of non-alcoholic fatty liver disease in upper body obesity  Samyah Shadid, Michael D Jensen  Clinical Gastroenterology.
Volume 42, Issue 4, Pages (April 2005)
Reply to: “DCD consensus and futility in liver transplantation”
Volume 69, Issue 2, Pages (August 2018)
Exercise Reduces Liver Lipids and Visceral Adiposity in Patients With Nonalcoholic Steatohepatitis in a Randomized Controlled Trial  David Houghton, Christian.
Defining cardiac adaptations and safety of endurance training in patients with m.3243A>G-related mitochondrial disease  Matthew G.D. Bates, Jane H. Newman,
Cheng-Yuan Peng, Rong-Nan Chien, Yun-Fan Liaw  Journal of Hepatology 
M. Sriharibabu, K. Komali, T. Sivakumar, Bhimasen Soren 
Amalia Gastaldelli, Giulio Marchesini  Journal of Hepatology 
Volume 70, Issue 1, Pages (January 2019)
Personalized Activity Intelligence (PAI) for Prevention of Cardiovascular Disease and Promotion of Physical Activity  Bjarne M. Nes, PhD, Christian R.
Volume 59, Issue 3, Pages (September 2013)
Volume 61, Issue 3, Pages (September 2014)
Volume 54, Issue 5, Pages (May 2011)
Volume 61, Issue 1, Pages S69-S78 (November 2014)
Volume 62, Issue 3, Pages (March 2015)
Volume 69, Issue 5, Pages (November 2018)
Volume 69, Issue 4, Pages (October 2018)
Amedeo Lonardo, Cesare Carani, Nicola Carulli, Paola Loria 
EASL Clinical Practice Guidelines: Wilson’s disease
Roberto de Franchis, Aleksander Krag  Journal of Hepatology 
The changing role of beta-blocker therapy in patients with cirrhosis
Reply to: “It takes two “eyes” to see in depth”
Volume 70, Issue 1, Pages (January 2019)
Variations in Vital Signs in the Last Days of Life in Patients With Advanced Cancer  Sebastian Bruera, Gary Chisholm, MS, Renata Dos Santos, MD, Camila.
Volume 65, Issue 2, Pages (August 2016)
Volume 57, Issue 5, Pages (November 2012)
Volume 69, Issue 5, Pages (November 2018)
Paul C. Adams, James C. Barton  Journal of Hepatology 
D. Jee, D. Lee, S. Yun, C. Lee  British Journal of Anaesthesia 
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies  The Emerging.
Global burden of alcoholic liver diseases
Volume 64, Issue 6, Pages (June 2016)
Is postspinal hypotension a sign of impaired cardiac performance in the elderly? An observational mechanistic study  J. Jakobsson, S.H. Kalman, M. Lindeberg-Lindvet,
Volume 63, Issue 1, Pages (July 2015)
Hepatorenal syndrome, MELD score and liver transplantation: An evolving issue with relevant implications for clinical practice  Paolo Angeli, Pere Gines 
International Journal of Cardiology
Effect of phenylephrine on the haemodynamic state and cerebral oxygen saturation during anaesthesia in the upright position  P.F. Soeding, S Hoy, G Hoy,
Pathogenesis of cholestatic hepatitis C
ACC/AHA 2017 definition of high blood pressure: implications for women with polycystic ovary syndrome  Lucas Bandeira Marchesan, B.Sc., Poli Mara Spritzer,
A 360-degree overview of paediatric NAFLD: Recent insights
Volume 75, Issue 1, Pages (January 2009)
The relationship between age and fat infiltration in liver and muscle
T. W. Jones, D. Houghton, S. Cassidy, G. A. MacGowan, M. I. Trenell, D
Associations of VO2peak to significant predictors.
Marie Boyle, Dina Tiniakos, Jorn M
Presentation transcript:

Volume 70, Issue 6, Pages 1203-1213 (June 2019) The degree of hepatic steatosis associates with impaired cardiac and autonomic function  David Houghton, Paweł Zalewski, Kate Hallsworth, Sophie Cassidy, Christian Thoma, Leah Avery, Joanna Slomko, Timothy Hardy, Alastair D. Burt, Dina Tiniakos, Kieren G. Hollingsworth, Roy Taylor, Christopher P. Day, Steven Masson, Stuart McPherson, Quentin M. Anstee, Julia L. Newton, Michael I. Trenell  Journal of Hepatology  Volume 70, Issue 6, Pages 1203-1213 (June 2019) DOI: 10.1016/j.jhep.2019.01.035 Copyright © 2019 The Authors Terms and Conditions

Journal of Hepatology 2019 70, 1203-1213DOI: (10. 1016/j. jhep. 2019 Copyright © 2019 The Authors Terms and Conditions

Fig. 1 Comparison of mean blood pressure, and low frequency/high frequency diastolic and systolic blood pressures between controls, and patients with NAFLD and DAFLD. Data are mean (SEM) for blood pressure, low frequency/high frequency ratio (sympathetic/parasympathetic, respectively) diastolic blood pressure and systolic blood pressure for controls (n = 34), patients with NAFLD (n = 46) and patients with DAFLD (n = 16) groups. * and ¥ denote a significant between group difference for all 3 groups (p <0.01) and a significant difference between NAFLD and DAFLD groups (p <0.05), respectively. Kruskal-Wallis test and within group differences using a Wilcoxon signed-rank (2-way) test both controlling for BMI. BMI, body mass index; DAFLD, dual aetiology fatty liver; NAFLD, non-alcoholic fatty liver disease and disease. Journal of Hepatology 2019 70, 1203-1213DOI: (10.1016/j.jhep.2019.01.035) Copyright © 2019 The Authors Terms and Conditions

Fig. 2 Relationships between metabolic and cardiac parameters. (A) F-glucose and CI, (B) HbA1c and resting HR, (C) HTGC and CI, (D) HTGC and SVI. *Spearman rank correlations were conducted to investigate any associations between baseline characteristics, resting central haemodynamic and cardiac autonomic measures for liver patients only, however, here we separate NAFLD and DAFLD for contrasting purposes only. CI, cardiac index; DAFLD, dual aetiology fatty liver disease; F-glucose, fasting blood glucose; HbA1c, glycated haemoglobin; HR, heart rate; HTGC, hepatic triglyceride content; NAFLD, non-alcoholic fatty liver disease; SVI, stroke volume index. Journal of Hepatology 2019 70, 1203-1213DOI: (10.1016/j.jhep.2019.01.035) Copyright © 2019 The Authors Terms and Conditions

Fig. 3 Relationships between hepatic triglyceride content and cardiac autonomic measures. Relationship between HTGC and (A) peak oxygen uptake (VO2peak), (B) peak HR, (C) LT, and (D) resting (RQ). *Spearman rank correlations were conducted to investigate any associations between baseline characteristics, resting central haemodynamic and cardiac autonomic measures for liver patients only, however, here we separate NAFLD and DAFLD for contrasting purposes only. DAFLD, dual aetiology fatty liver disease; HTGC, hepatic triglyceride content; HR, heart rate; LT, lactate threshold; NAFLD, non-alcoholic fatty liver disease; RQ, respiratory quotient. Journal of Hepatology 2019 70, 1203-1213DOI: (10.1016/j.jhep.2019.01.035) Copyright © 2019 The Authors Terms and Conditions